Dynamic treatment regimes are set rules for sequential decision making based on patient covariate history. Observational studies are well suited for the investigation of the effects of dynamic treatment regimes because of the variability in treatment decisions found in them. This variability exists because different physicians make different decisions in the face of similar patient histories. In this article we describe an approach to estimate the optimal dynamic treatment regime among a set of enforceable regimes. This set is comprised by regimes defined by simple rules based on a subset of past information. The regimes in the set are indexed by a Euclidean vector. The optimal regime is the one that maximizes the expected counterfactual utility over all regimes in the set. We discuss assumptions under which it is possible to identify the optimal regime from observational longitudinal data. Murphy et al. (2001) developed efficient augmented inverse probability weighted estimators of the expected utility of one fixed regime. Our methods are based on an extension of the marginal structural mean model of Robins (1998 Robins ( , 1999 which incorporate the estimation ideas of Murphy et al. (2001) . Our models, which we call dynamic regime marginal structural mean models, are specially suitable for estimating the optimal treatment regime in a moderately small class of enforceable regimes of interest. We consider both parametric and semiparametric dynamic regime marginal structural models. We discuss locally efficient, double-robust estimation of the model parameters and of the index of the optimal treatment regime in the set. In a companion paper in this issue of the journal we provide proofs of the main results.
Introduction
Dynamic treatment regimes are set rules for sequential decision making based on patient covariate history. In the last decade, major developments in methods for estimating the e¤ects of dynamic treatment regimes from observational data emerged, speci…cally with a series of papers by Robins (1986 Robins ( , 1989 Robins ( , 1993 Robins ( , 1997 . In these papers Robins considers the use of structural nested models to estimate a variety of causal contrasts. In his 1993 paper, Robins raised the possibility of estimating dynamic treatment regime e¤ects by censoring subjects the …r s t time they fail to adhere to the dynamic regime. Murphy, van der Laan and Robins (2001) implemented this idea and applied it to the estimation of the mean of a potential outcome under one dynamic treatment regime, possibly conditional on baseline covariates.
An important public health question related to the management of chronic diseases is to determine the optimal dynamic treatment regime among those in a set of simple regimes that can be enforced in practice. Recently, the task of estimating the optimal dynamic treatment regime from observational data has seen major methodological developments, speci…cally with the seminal paper of Murphy (2003) and the subsequent work on doubly-robust g-estimation of optimal regime structural nested mean models of Robins (2004) . Until these papers, the Biostatistical community had regarded the problem of …n d i n g optimal treatment regimes from longitudinal observational databases as a very hard, nearly intractable, problem for the following reasons: i) methods for estimation of treatment e¤ects have to appropriately control for high dimensional time dependent confounders (i.e. time varying risk factors that a¤ect future treatments) that are themselves predicted by past treatments; standard longitudinal regression methods which adjust for time dependent risk factors generally yield biased estimators of the time dependent treatment e¤ects (Robins, 1997) and, ii) the determination of an optimal treatment strategy is a high dimensional sequential decision problem. Speci…cally, because the treatment to be prescribed at each time k is decided based on updated information, the set of all potential dynamic regimes, from which the optimal regime needs to be identi…ed, is very large.
Murphy and Robins' methods have one important limitation; they optimize over a class of regimes in which the decision maker has access to very rich information on the patient's covariate history, this being comprised by an increasing sigma …e l d of either a subset or all of the time dependent confounders for treatment. With such rich information, the optimal rule may well be a very complicated function of past covariate history, one that may be hardly enforceable in most health care settings. The methods we will de-velop in this paper are suitable for …n d i n g the optimal regime out of a smaller class of regimes in which treatment decisions are based on limited information about the patient's covariate history. Our methods are based on an extension of the marginal structural mean (MSM) model of Robins (1998 Robins ( , 1999 which incorporate estimation ideas of Murphy et al. (2001) . Our model, which we call dynamic regime marginal structural mean model, is specially suitable for estimating the optimal treatment regime in a moderately small class of enforceable regimes of interest.
The idea of using dynamic regime MSM models as a device to estimate optimal treatment regimes was …r s t introduced in Andrea Rotnitzky's NIH grant proposal submitted in November 2005, where it was also indicated how double-robust locally e¢ cient inverse probability weighted estimators of the model parameters could be constructed. This proposal had been developed in collaboration with Liliana Orellana and James Robins. The methods were further investigated and extended in Liliana Orellana's Ph.D. thesis at the Department of Biostatistics of Harvard School of Public Health, during the period [2005] [2006] [2007] . During the same period similar ideas were independently developed by Mark van der Laan and were reported in van der Laan (2006) , van der Laan and Petersen (2007) and later illustrated in Bembom and van der Laan (2008) for estimation of the optimal treatment regimes from sequentially randomized trial data. In this paper we report in detail the results developed in Orellana's Ph.D. thesis (2007) . Some of these results without proofs were included in the overview paper Robins, Orellana and Rotnitzky (2008) . These results di¤er from and extend the results in van der Laan (2006) and van der Laan and Petersen (2007) and Bembom and van der Laan (2008) in a number of ways. First, these papers considered only parametric models for the dependence of the mean of the counterfactual outcome on the dynamic treatment regime. Here we consider also the more ‡e x i b l e semiparametric MSM models. Second, van der Laan and Petersen derived, as we do here, a class of doublerobust estimators of the dynamic regime MSM parameters but did not discuss the e¢ cient choice in the class. Here we derive this e¢ cient choice and propose an estimator that has smallest asymptotic variance among all double-robust (DR) estimators regardless of which of the two working models postulated to construct the DR estimator is correct. Third, of the three aforementioned articles, only Bembom and van der Laan (2008) discuss the construction of con…dence regions about the index of the optimal regime in the class, but they do it assuming the class is uncountable and indexed in a continuum. Here we consider the important special case in which the class is …n i t e , a case which raises non-trivial technical challenges.
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The International Journal of Biostatistics, Vol. 6 [2010] , Iss. 2, Art. 8 DOI: 10.2202 /1557 -4679.1200 regime MSM models can be derived from the general theory for inference in models for coarsened at random data developed by Robins and Rotnitzky (1992) . We are aware that the general theory in that paper (and later exposed and specialized to many examples in a number of papers (e.g. Robins, Rotnitzky and Zhao, 1994 , Robins, 1998 and 1999 and books (van der Laan and Robins, 2003 , Tsiatis, 2006 ) is di¢ cult to follow for the average reader of methodological statistical journals. With this in mind, in this paper we present the proposed methods in an expository manner, providing discussion and examples of the key assumptions they rely on, and of the modelling steps and algorithms required to compute the proposed estimators. Furthermore, we provide a step-by-step derivation of certain optimality and double-robustness properties that are a consequence of the Robins-Rotnitzky general theory for inference in coarsened at random models. In addition, with the intention of making the presentation self-contained in a companion paper in this issue of the journal (Orellana, Rotnitzky and Robins, 2010) we provide proofs of key results that appeared elsewhere in earlier papers of Robins and colleagues. This paper is organized as follows. In Section 2 we introduce notation, the data structure, the concept of dynamic treatment regimes and the de…nition of the potential variables. In Section 3 we discuss a set of assumptions that allows identi…cation of the expected utility in the hypothetical world in which everybody follows a given dynamic regime and we derive the expression of this expected utility as a functional of the observed data law. In Section 4 we introduce dynamic regime parametric and semiparametric marginal structural mean models (MSM). In Section 5 we propose augmented (AIPTW) and non-augmented inverse probability of treatment weighted (IPTW) estimating equations for the parameters of the dynamic regime MSM models. We derive their asymptotic distribution and we use this asymptotic distribution to guide the derivation of a class of locally e¢ cient AIPTW estimators indexed by a function b: In Section 6 we motivate and discuss the double-robustness property of each locally e¢ cient AIPTW estimator in the class. We discuss double-robust inference (variance estimation and con…dence regions) for the parameters of the dynamic MSM models and for the optimal treatment regime. In Section 7 we derive the optimal index b and propose an estimator that is double-robust and locally e¢ cient in the class of all AIPTW estimators of the parameters of the dynamic regime MSM models. In Section 8 we provide a discussion of some limitations of our proposal.
The methods for estimation and inference of the parameters of dynamic 2 General Formul at i on
The Setup
Suppose that a registry contains observational data about a group of patients, all of whom were followed from an agreed upon baseline event until at least the end of K time intervals or until their death time, whichever came …r s t . Patients came to the clinic once during each of the K equidistant intervals to have various clinical and laboratory measurements made. Assume that clinic visits happened at the end of the interval. Furthermore, assume that no patient missed a clinic visit. Treatment decisions, i.e. whether to start, switch, discontinue or alter the dose of a treatment, were made by the physicians after examining the patient's laboratory and clinical data results. Thus, treatment decisions were made soon after each clinic visit and at no other moment. Assume that the subjects in the registry are a random sample from a large population of interest.
Each record of the database contains the patient's information recorded over the entire follow-up period. This is comprised by the variables
where R k is a binary indicator for being at Risk, that takes the value 0 if the patient has experienced an event of interest by time k and 1 otherwise (this event often being death, but possibly also being the onset of a disease, such as the onset of a symptom de…ning AIDS), the variable T k denotes the minimum between the time to the event of interest and k (here and throughout the unit measure for time is 1 unit = length of one inter-visit interval, and time to event is measured since time of start of follow-up), L k are the clinical and laboratory variables measured during the k th clinic visit if the patient was alive, A k is the subsequent treatment prescription which we assume takes values in a …n i t e set A k . In the database, the entries for L k and A k at a time k after the patient experienced the event of interest, e.g. death, are set to any agreed upon value such as NA, or the last measured values of these variables. The chosen convention is inconsequential for any analysis method that, like the one presented in this article, disregards the entries of these variables after the occurrence of event. To avoid notational burden, we will assume that the entries for the post-event variables L k and A k are set equal to the last available values for these variables. One …n a l outcome measurement L K+1 is available for all subjects in the registry that have not yet experienced the event at time K + 1.
The Treat ment Regime
A dynamic treatment regime is a sequential rule for determining, at each time k; the next treatment prescription A k : The rule may depend on part or all of the recorded health information about the patient's health up to and including time k. Formally, a dynamic treatment regime is de…ned by a collection of maps o k 7 ! g k (o k ) 2 A k ; k = 0; :::; K:
Because we are interested in evaluating the e¤ect of treatment regimes on the health experience of the patient up to the development of the event of interest, in principle, we can de…ne the treatment regime arbitrarily for times k after the occurrence of the event. For example, a treatment rule is meaningless if the patient is dead and in principle, we could de…ne g k (o k ) arbitrarily at any month k after death. However, because our methods require that we use the same convention for coding data after the event time in the hypothetical world in which everyone followed regime g as in the actual world, and in view of the aforementioned convention for coding variables after the event time, we set
Remark 1: Some authors de…ne dynamic treatment regimes as a collection of functions mapping each (o k ; a k 1 ) to an element of A k . However, for the purposes of evaluating the e¤ect of a dynamic regime that it is enforced since k = 0, this de…nition is redundant because when a given dynamic regime is enforced, the treatments received up to time k 1 are functions of the outcomes obtained up to time k 1; so the domain of the decision rule at time k depends only on past outcomes.
Example 1: Consider a registry that contains information about a cohort of HIV-infected patients followed since their …r s t doctor's visit after infection. Suppose that patients in the registry return monthly to the clinic for clinical and laboratory tests. Suppose all patients have been followed until month K + 1 = 37 from baseline or until their death time, whichever came …r s t and that death occurrence was recorded in continuous time. Patient information includes CD4 cell count and viral load recorded at the clinic visit as well as the treatment prescription. Assume that treatment decisions, i.e. whether or not to give highly active antiretroviral-therapy (HAART), are made at and only at, a clinic visit. Formally, the variables entered into the registry corresponding to month k; k = 0; :::; K + 1 = 37; are O k = (R k ; T k ; L k ) where T k is equal to the minimum between i) death time, ii) the time to the occurrence of an AIDS de…ning event and iii) k, R k = 1 if the subject is alive and AIDS free at the beginning of month k and R k = 0 otherwise. The variables A k and L k = (CD4 k ; V k ) are de…ned as follows. At a month k at which the subject is at risk CD4 k is the subject's CD4 cell count, V k is the logarithm of his/her viral load and A k denotes the treatment prescription right after measuring CD4 k and V k (0 if no HAART is given, 1 otherwise). At any month k at which R k = 0, L k and A k are set to the values of the health outcomes and treatment indicator recorded at the last visit k 0 < k at which R k 0 was 1. A treatment regime that speci…es that the patient must start HAART as soon as it is detected that his/her CD4 count is or was at or below 350 cell count= L; and must continue on HAART afterwards is a dynamic treatment regime de…ned by the set of functions fg k : k = 0; :::; Kg where
The Potential Va ri a bl e s
To de…ne the causal e¤ects of distinct dynamic treatment regimes we use the notion of potential, also called counterfactual, variables introduced by Neyman (1923) and Rubin (1978) for time independent treatments and later extended by Robins (1986 Robins ( , 1987 to the context of time dependent treatments.
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of a subject if he/she had followed, possibly contrary to fact, the treatment pattern A = a: The set
denotes all possible vectors of potential outcomes and event indicators for a random patient from the population. This set includes vectors O (a) that encode potential outcomes under the scenario in which treatment alterations occur after the event of interest, obviously a meaningless situation if the event is death. These meaningless variables will never be used in the methods that we will describe here and we include them in the set O only to avoid the extra notational burden needed to exclude them from it. The notation de…ning O makes the implicit Stable Unit Treatment Value Assumption (SUTVA) (Cox, 1958 , Rubin, 1978 that one subject's potential variables do not depend on the treatment patterns followed by other subjects. SUTVA implies the following assumption connecting the vector O with one speci…c member of O.
Consistency Assumption (C). For each k = 1; :::; K + 1; the vector ) are random vectors on an underlying probability space ( ; F; P) whose probability laws we denote with P and P g . The marginal distribution of O; throughout denoted as P O ; is the same under either P or P g because the potential variables in the set O are, like age and gender, …x e d patient characteristics and hence una¤ected by the treatments actually followed by the subject. In contrast, the distribution of (O; A) and (O g ; A g ) are di¤erent. Speci…cally, if I U ( ) denotes the indicator function that takes the value 1 if is in U and 0 otherwise then
because in the world in which everybody follows regime g; the treatment assignment at time k is equal to g k O k with probability 1. In contrast,
is the probability that in the actual world treatment a k is prescribed at time k for a patient with observed past 
V k is a user-speci…ed utility function that quanti…es the health status at time k of a patient with recorded CD4 history CD4 k and recorded log-viral load history
If Z denotes a subset or possibly all of the baseline vector L 0 de…ning subpopulations of interest; then the conditional mean
is the expected utility for the subpopulation of subjects who have baseline covariates Z equal to z, in the hypothetical world in which they all follow the treatment regime g: Comparison of the expected utility m (z; g) for di¤erent regimes g of interest quanti…es the causal e¤ects for the subpopulation with Z = z: Thus, m (z; g) is a target parameter for inference when evaluation of the causal e¤ect of regime g is of substantive interest. The consistency assumption C implies that in the database we will have the records of (O g ; A g ) for all the study participants that actually obeyed regime g (since for them, their recorded data (O; A) agrees with their potential data (O g ; A g )): However, data on (O g ; A g ) will be unavailable for those that did not obeyed regime g: This fundamental missing data problem implies that m(z; g) will generally not be identi…ed from P marg unless certain assumptions are made.
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Identifying Assumptions
In this subsection we state and discuss two assumptions that are standard in the causal inference literature which, when made in conjunction with assumption C, imply the identi…ability of m (z; g) from the law P marg .
Sequential Randomization (SR): A k is conditionally independent of O given O k and A k 1 ; for each k = 0; :::; K.
Assumption SR would be true in a sequentially randomized trial in which treatment at each time k was randomly assigned with probabilities depending on the subject's recorded history. In an observational study, the assumption cannot be empirically tested (Robins, 1997) . Thus, investigators will need to use their subject matter knowledge to collect data on many relevant variables so that the assumption is at least approximately correct. Murphy et al. (2001) studied conditions for identi…cation of m (z; g) when L k can be decomposed into (S k ; V k ) ; u (O; A) = S K+1 and the regime g is such that g k at each time k depends on O k only through the subvector (S 0 ; :::; S k ) : They showed that in this special case, a slightly weaker version of the SR assumption which stipulates independence of A k solely with the S ( ) parts of O, together with the PO assumption, su¢ ces for identi…cation of m (z; g) :
Assumption PO is tantamount to assuming that if in the scenario in which regime g were to be enforced in the entire population, subjects with outcome history o k and treatment history a k 1 were to exist and were to be assigned to a k at time k then, in the observational world (i.e. the setting under which the study data are collected) there must also exist subjects with outcome history o k ; treatment history a k 1 who take treatment a k . The intuition behind assumption PO is simple. If we want to learn about the distribution of the outcome in the hypothetical world in which regime g was implemented from data in the actual observational study, then every subject in our study population must have a positive chance of following regime g: To see this, consider the subpopulation, say P; comprised of subjects that if regime g were enforced up to time k 1, they would follow it and would have O
Suppose that a subset of subjects in P actually followed regime g up to time k 1 in the observational study. The sequential randomization assumption implies that those from this subset that would continue to follow regime g at time k; (i.e. those with A k = g k (o k )) are representative of the others in this subset that depart from regime g at this cycle. However, suppose that none in this subset has A k = g k (o k ) : Then, in our dataset all subjects from the sub-population P have departed from regime g at time k or earlier and as such we have no representative from this subpopulation that follows regime g for the entire follow-up period. Then, unless we make further untestable assumptions relating the distribution of O g in subpopulation P with the distribution of O g in other subpopulations, we have no way to learn from the observational data the outcome distribution that subjects from P would have if they followed regime g for the entire follow-up period. In Section 4 of the companion paper (Orellana, Rotnizky and Robins, 2010) we provide an example illustrating this point.
Another point of note about assumption PO is that it is an assumption only about the recorded treatments that represent true treatment assignments. That is, if R k = 0, i.e. if the absorbing event has occurred by time k; then the assumption does not actually place restrictions on the probabilities of the arti…cially de…ned treatment variables A k : To see this note that if subjects with past o k exist in both the hypothetical and the observational world, then the next recorded treatment will automatically take the same value in both worlds when the event indicator r k is 0 because, by convention, this next treatment will agree with the previous recorded treatment value a k 1 :
Identi…cation Lemma
Under the convention 0=0 = 0; assumption PO implies that the functions
are well de…ned for all k = 0; :::; K and all l > 0 such that k + l K. In the product (4), k can be replaced by k k (o k ; a k ) ; the minimum between k and the last visit time prior to the occurrence of the event of interest when
by convention, A k at a time k after the absorbing event has occurred is set to the last previously prescribed treatment).
The following key Lemma due to Robins (1986 Robins ( , 1987 ) (see also Robins, 1997, and Murphy, van der Laan and Robins, 2001) , implies that under assumptions C, SR and PO, the law P marg g of the outcomes and treatments that
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is absolutely continuous with respect to P marg and
In part 1 of the Lemma, we used the notation
Part 2 of the Lemma implies that under assumptions C, SR and PO, if p marg g and p marg denote (versions of) the densities of P marg g and P marg (with respect to some dominating measure), then
where throughout we remove the subscript indicating the variables intervening in any given density; the lower case letters where they are evaluated indicates the random variable that the density correspond to, e.g. we write
(o j jo j 1 ; a j 1 ) : In contrast, part 1 of Lemma 1 informally states that among subjects that in the actual world followed regime g until time k 1 and had observed outcome history o k until time k; the joint density (with respect to some dominating measure) of the outcome and treatments (O g ; A g ) that they would have if they continued to follow regime g until time K is
Note that the counterfactual law P marg g has the same conditional law of O j given O j 1 ; A j 1 as the observational law P marg for all j = 0; :::; K + 1; but it di¤ers from P marg in that the conditional probability of A j given O j ; A j 1 is the mass point probability I fgj(Oj)g (A j ) rather than the conditional probability j A j jO j ;A j 1 : This replacement is not surprising since P marg g is the law of the treatments and outcomes in the hypothetical world in which everybody follows treatment regime g; and in such a world, A j is a deterministic, i.e. non-random, function of O j : On the other hand, sequential randomization and positivity ensures that the conditional law of O j given O j 1 ; A j 1 is the same as the conditional law of O 
In equation (5) the numerator of ! K O K ;A K is di¤erent from 0 for subjects that actually followed treatment regime g and the denominator of ! K O K ;A K is the probability that a subject with counterfactual O follows the treatment regime g. Thus, ! K O K ;A K censors subjects that did not follow regime g:The weights are just the right ones to represent the censored subjects with the appropriate uncensored subjects. In fact they e¤ectively produces a strati…ed redistribution to the right operation in which non-compliers to regime g are censored the …r s t time they do not comply and their contribution is redistributed among those that have the same covariate and treatment history and that remain compliers. This redistribution produces the right estimand because, by the sequential randomization assumption SR, among those with the same past, compliance status at a given time is the result of a random mechanism that is independent of the future health outcomes that the subjects would experience if they were to comply with regime g: The redistribution process is tantamount to creating clones of each all-time complier. The compliers and their clones form a pseudo-population with the same distribution of O g as in the study population, in which everybody followed regime g:
12
The International Journal of Biostatistics, Vol. 6 [2010] , Iss. 2, Art. 8 DOI: 10.2202 /1557 -4679.1200 expectation on the right hand side of the equality is an integral with respect to the measure P marg : The rightmost member of the equalities is the so-called Gcomputation-algorithm (Robins, 1986) . After recursive applications of Fubini's theorem (see proof of Lemma 1, Section 2.1 companion paper), this formula has the following alternative expression
where 1 (o 0 ) is de…ned recursively from,
Lemma 1 entails the following further elaborations, proved in Section 2.2 of the companion paper (Orellana, Rotnitzky and Robins, 2010) , on the meaning of the function k+1 (o k ) under assumptions C, SR and PO. a) In the hypothetical world in which treatment regime g is implemented in the entire population, k+1 (o k ) is the utility mean among subjects who have history
is the utility mean among subjects that in the observational world had covariate history O k = o k at time k and that actually followed regime g up to time k 1 if, possibly contrary to fact, these subjects were to continue to follow regime g from time k until time K; i.e.
Factoring the law of
formula (6) implies that, under C, SR and PO, the function m
)jZ = ] depends on P marg only through the laws entering the L O -part of its factorization. We will return to this point in Section 6. The equality (6) proves that m (z; g) is identi…ed by P marg because the
Dynamic Regime Marginal Structural Mean Models
In order to choose the best (enforceable) course of action for subjects with baseline covariates Z = z, one will want to …n d the regime
given class of candidate regimes R = fg x : x 2 X g : That is, one will want to …n d
where throughout, without loss of generality, we assume that higher values of the utility function are preferable.
The treatment regime g xopt(z) is the optimal treatment regime among regimes in the class R for subjects with baseline values Z = z: Murphy (2003) and Robins (2004) considered the problem of estimating optimal dynamic treatment regimes from observational longitudinal data. In these authors' work, the class R is very large; it is comprised of g's such that the g' k s are arbitrary functions of (the increasing sequence of) sigma …e l d s F k = (O 0 ; O 1 ; :::; O k ) where the O j 's are (possibly di¤erent) subsets of the time dependent covariates O j . However, as indicated in the introduction, often the class R of candidate (enforceable) regimes is signi…cantly smaller, usually comprised of functions g k that can depend only on limited covariate history information. For example, consider the pressing question in AIDS research of which is the optimal threshold CD4 count value at which to start prescribing HAART to HIV positive subjects. In this setting, interest lies in …n d i n g the optimal regime in the set R in which g x is de…ned as in (2) but with 350 replaced by x and X is the interval [200; 600] : This interval includes the set of scienti…cally relevant CD4 count/ L threshold values. The class R of candidate regimes is much smaller than the class R of all dynamic regimes which includes rules that can possibly depend on past CD4 count in any complicated way. Murphy (2003) and Robins'(2004) methods can estimate the optimal treatment regime in the class R but not in the class R.
In what follows we will consider estimation of x opt (z) when the set R of regimes of interest is possibly smaller than that considered in Murphy's and Robins' work. We will assume that R can be indexed by the elements of a set X that is either discrete, i.e. …n i t e or countable, or a subset of R s with no isolated points.
Although under assumptions C, SR and PO for all g x , x opt (z) is identi…ed by P marg for each z; in practice we cannot hope to estimate it well with the argmax of the individually estimated values of m (z; g x ) : This is so because:
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where h par (z; x; ) is a known smooth function of a p 1 parameter and is unknown. For instance, in example 1 of Section 2.2 we might choose
4 (x x ) 2 z + 5 + 6 z with x the index of an arbitrary regime, e.g. x = 350. This model postulates that the function m (z; g x ) is equal to 5 + 6 z and that the di¤erence m (z; g x ) m (z; g x ) is a quadratic function of (x x ) with coe¢ cients which depend linearly on z: For the purposes of estimating x opt (z) ; model (10) is unnecessarily stringent. Speci…cally, for any …x e d index x the optimal index x opt (z) satis…es
Thus, for inference about x opt (z) it su¢ ces to model the di¤erence m (z; g x ) m (z; g x ). However, model (10) places parametric restrictions in the form of the dependence on z of not only the di¤erences m (z; g x ) m (z; g x ) but also of the function m (z; g x ) : This latter unnecessary parametric restriction may lead to invalid inference about x opt (z) : For instance, model (11) makes the unnecessary assumption that m (z; g x ) is a linear function of z: If in fact, m (z; g x ) is not linear in z; then estimators of x opt (z) computed under this assumption will generally be inconsistent. This remark suggests that in order to reduce the chance of invalid inference about x opt (z) due to model misspeci…ca-tion and to retain the possibility of borrowing information across treatments and baseline covariates, we consider (following Robins, 1999 ) ‡e x i b l e semiparametric models of the form
where q ( ) is an unknown function of z only, is an unknown p 1 parameter and for each z and x; h sem (z; x; ) is a known smooth function of satisfying h sem ( ; x ; ) = 0 for the index x of an arbitrary, user-speci…ed, regime. For example,
The condition h sem ( ; x ; ) = 0 implies that q (z) is equal to m (z; g x ) ; the expected utility function for the regime x ; and hence that h sem (z; x; ) = m (z; g x ) m (z; g x ) : Thus, to estimate x opt (z) it su¢ ces to estimate the value of x maximizing h sem (z; x; ) :
So long as h sem (z; x; ) = 0 for some value of the vector ; model (12) is guaranteed to be correctly speci…ed under the null hypothesis that all treatments regimes g x are equally e¤ective. Thus, inference under model (12) are guaranteed to result in valid level tests of indi¤erence between treatment regimes. In contrast, inference under model (10) do not generally share this robustness property. Which model (10) or (12) should one adopt for estimation of ; and hence of x opt (z) ; raises the usual bias/e¢ ciency trade-o¤ considerations: if model (10) is indeed correctly speci…ed then, in general, estimators of x opt (z) that are nearly e¢ cient under model (10) will be more e¢ cient than estimators of x opt (z) that are nearly e¢ cient under model (12) ; however the former will be inconsistent if model (10) is incorrect and model (12) is correct while the latter will be consistent under this circumstance. In our opinion, unless …r m scienti…c background warrants model (10) ; model (12) should be preferable for inference about x opt (z) as it provides the data analyst a better chance to carry out valid inference about x opt (z).
Relaxing the positivity assumption: Under (10) or (12) ; m (z; g x ) ; and consequently x opt (z) ; may be identi…ed by P marg for all x 2 X even when the positivity assumption PO fails for some g x . For instance, under model (10) identi…cation of su¢ ces for identi…cation of m (z; g x ) for all x 2 X . Yet, for example, when h par (z; x; ) is de…ned as in (11) ; is identi…ed provided m ( ; g x ) is identi…ed for three di¤erent values of x in X . Thus, to identify m (z; g x ) for all x 2 X it su¢ ces that the PO assumption is satis…ed for all g x with x 2 X pos where X pos is any subset of X comprised of at least three di¤erent x values. Throughout, for any subset C of X , PO(C) will stand for the assumption that stipulates that PO holds when g is replaced by g x for all x 2 C: Furthermore, we will let X pos denote any subset of X such that when PO(X pos ) holds, then is identi…ed. We will assume that X pos is discrete (…nite or countable) or otherwise that it is a subset of R s without isolated points.
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Inference
By de…nition, under model DYR-Par-MSM, assumptions C, SR and PO(X pos ) hold. Thus, in view of (5), the model is equivalently de…ned by these assumptions and the restriction
where
Likewise, model DYR-Sem-MSM is de…ned by assumptions C, SR and PO(X pos ) and
for all x 2 X pos ; q ( ) unknown.
Assumptions C and SR do not impose restrictions on the law P marg of (O; A) (Gill, van der Laan and Robins, 1997) . Thus, as models for P marg ; models DYR-Par-MSM and DYR-Sem-MSM are de…ned as the set of laws P marg satisfying the PO(X pos ) assumption and the restrictions (14) and (15) respectively. Note that, although not immediately apparent, (15) does indeed impose restrictions on P marg because the random variables ! x K O K ;A K fu (O; A) h sem (x; Z; )g depend on x yet the condition (15) imposes that they have the same conditional expectation given Z regardless of the value of x:
Because the data available to us are a random sample of (O; A) from the law P marg ; then to conduct inference about we can ignore the fact that has a causal interpretation, and regard it simply as a parameter in the model for P marg determined by the restriction (14) or (15) under consideration and the PO(X pos ) assumption. We take this point of view in our construction of estimators of and denote the models for the law P marg determined by the PO(X pos ) assumption and restriction (14) = (15) as DYR-Par-MSM-obs and DYR-Sem-MSM-obs models:
Restrictions (14) and (15) are not directly applicable for construction of estimators of because the weights ! x K O K ;A K depend on the unknown o k ; conditional treatment probabilities k (a k j a k 1 ) ; k = 0; :::; K; de…ned in (3) which cannot be non-parametrically estimated well using smoothing techniques due to the curse of dimensionality. One strategy for dimension reduction, that we adopt in this paper, is to consider estimation of under models DYRPar-MSM-obs and DYR-Sem-MSM-obs de…ned like DYR-Par-MSM-obs and DYR-Sem-MSM-obs but with the additional assumption
where for each a k ; o k and a k 1 ; k (a k jo k ; a k 1 ; ) is a known smooth function and is an unknown q 1 parameter vector. For instance if A k = f0; 1g ; we may consider a logistic regression model
for some q 1 vector-valued, user-speci…ed, function e k (o k ; a k 1 ) and 0 = 0 ; :::; q 1 : The choice of I fa k 1 g (a k ) for k when r k = 0 is made in accordance with our convention for assigning values to A k corresponding to times k after the event has occurred, which stipulates precisely that A k is equal to A k 1 if the event has already occurred by time k. We de…ne k in this way so that when we compute the denominator of ! x K O K ;A K from the data recorded in the study database, the factors k A k jO k ; A k 1 ; for the times k after the event has occurred will be equal to 1, and hence will not contribute to the calculation of ! 
Estimators of
and of x opt (z)
To de…ne our estimators of we will use the following conventions: the expression a:e: (X pos ) next to a statement stands for the assertion that the statement holds for all x in X pos except on a subset of X pos of measure 0, where is the counting measure if X pos is discrete (…nite or countable) and is the Lebesgue measure on R s otherwise; G stands for the sigma …e l d of all subsets of X pos if X pos is discrete, and for the Borel sigma-…eld of X pos otherwise; P X denotes a measure on (X pos ; G) which is mutually absolutely continuous with the restriction Xpos of to X pos . Even though our derivations will not require that P X be a speci…c one, when X pos is bounded, we will take P X to be the uniform measure. The formalism of de…ning a generic P X is needed to be able to accommodate settings with unbounded sets X pos . Nevertheless we will argue in Remark 2 below that the choice of P X is essentially inconsequential.
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Because our estimators and their properties can be derived arguing essentially identically in both models DYR-Par-MSM-obs and DYR-Sem-MSMobs , then to avoid redundancy, throughout we use the subscript in every instance in which the de…nitions and results being derived hold indistinctly if is replaced by par or by sem: For = par and = sem de…ne
and 
The following Lemma, whose proof is given in Section 2.3 of the companion paper (Orellana, Rotnitzky and Robins, 2010) , provides the key result for the derivation of our estimators. We are now ready to describe our estimators of and of x opt (z) : Our estimators require two inputs from the data analyst, the …r s t input is a (column) vector-valued function b (x; z) of the same dimension as ; the second input is a collection of (column) vector-valued functions fd k (o k ; a k )g k=0;:::;K , each function also being of the same dimension as : Each choice of b and fd k g k=0;:::;K will result in a di¤erent estimator which we denote with b 
Stage 2: if model DYR-Par-MSM-obs was assumed, compute b
and if model DYR-Sem-MSM-obs was assumed compute b sem (b; d) solving
In the preceding algorithm we adopted the convention, that we will also adopt throughout, that for n i.i.d: copies V 1 ; :::; V n of any random vector V; 
To simplify notation, we will use b par (b) and b sem (b) to denote the estimators solving these reduced equations. Lemma 2 implies that when model (16)
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The International Journal of Biostatistics, Vol. 6 [2010] The left hand sides of the equations in displays (17) and (18) are the difference of two terms, the term P n fS par ( ; b ; b)g and the term P n fS aug (b ; d)g. The …r s t term is a sum (or integral) over x 2 X pos of x speci…c estimating functions P n f! x K (b ) U par (x; ; b)g and P n f! x K (b ) U sem (x; ; b)g : These x speci…c estimating functions are sums only over subjects whose data are consistent with having followed regime g x and their contribution to the sum is equal to the functions U par (x; ; b) and U sem (x; ; b), weighted by the inverse of the product of the occasion-speci…c estimated conditional probabilities that at each occasion they took the treatment they actually took given their recorded history of outcomes and treatments at that occasion. Subjects that did not follow regime g x contribute indirectly to these x speci…c estimating functions through the estimate b of in the model for the treatment probabilities. In contrast, the second term P n fS aug (b ; d)g is a sum over all subjects, regardless of whether or not they followed any given regime g x : This term does not depend on ; but with clever choices of functions fd k g k=0;:::;K , its inclusion can help improve the e¢ ciency with which is estimated. This point is elaborated in Section 5.3.
Under (10) and (12) ; the functions U par (x; ; b) and U sem (x; ; b) respectively would have mean zero at in a study in which subjects are randomized to the sequence of treatments A k ; k = 0; :::; K; at baseline (with randomization probabilities that may depend on Z) but do not generally have mean zero in an observational study. Weighting by ! x K O K ;A K creates pseudo-samples from a pseudo-population in which all subjects followed regime g x : Thus, weighting by an estimator of ! x K O K ;A K and summing over all x 2 X pos ; implicitly removes bias by creating, for large samples, a pseudo-sample from a pseudopopulation in which subjects were assigned with equal probability to each of the regimes g x ; x 2 X pos (Hernán, Brumback and Robins, 2000) .
In accordance with similar terminology used in estimation of standard, i.e. non-dynamic, marginal structural models (Robins, 1999) we refer to the estimator b (b) as an inverse probability of treatment (IPTW) estimator and to the estimator b (b; d) (with non-zero d' k s) as an augmented inverse probability of treatment (AIPTW) estimator.
A point of note is that a given subject may follow more than one regime g x and thus contribute a term to more than one x speci…c estimating function P n f! X =dP X . Example 1 (continuation): returning to example 1 of Section 2.2 suppose that our goal is to …n d the optimal CD4 level at which to start treating HIV+ subjects with HAART. Suppose that for each integer x in the interval [200; 600] there exist subjects in the population which started HAART as soon as it was detected that their CD4 count fell below x. In such case X pos is the set of integers in [200; 600] while X is the entire interval [200; 600] : In this example, we take P X to be the uniform probability over the integers in [200; 600]; so integrals over X pos with respect to P X are simply averages over the integers x in [200; 600]. Suppose that the endpoint of interest, i.e: the utility, is de…ned to be equal to the time since baseline to the …r s t occurrence of either death from any cause or diagnosis of clinical AIDS, if at least one of these two events occurred during the 37 months of follow-up, and to be equal to 72 months otherwise. The value of 72 months is chosen to represent the expected time since baseline to the occurrence of death or …r s t diagnosis of clinical AIDS for subjects that are still alive and AIDS free at month 37. Thus, we write
Furthermore, suppose that h par (z; x; ) and h sem (z; x; ) are like in (11) and (13). To compute IPTW and AIPTW estimators of we need to postulate …r s t a parametric model k (a k jo k ; a k 1 ; ) for the treatment probabilities k (a k jo k ; a k 1 ). For example, we may choose
if r k = 1 and a k 1 = 0 with school, hmo and druguse being baseline binary indicators of completion of high school, a¢ liation with an HMO and drug use respectively, year is the calendar year of start of follow-up, CD4 k and V k ; recall, are the CD4 count and the log-viral load at time k respectively: The choice of k when r k = 1 and a k 1 = 1 re ‡ects the fact that in our example the probability that A k = 1 is 1 when R k = 1 and A k 1 = 1 because we have assumed that once an assignment to take HAART was made, it remained in place for the rest of the follow-up period. As discussed earlier in this Section, the choice of I fa k 1 g (a k ) when r k = 0 is made so that there is no contribution to the product in the denominator of ! K O K ;A K after the event of interest has occurred. Consider next the two stages of the algorithm to compute the IPTW and AIPTW estimators. In stage 1, the estimator b of is e¤ectively computed by pooled logistic regression with multiple contributions from each subject. Subject i contributes to the pooled logistic regression with the outcome A k;i and the covariates e k O ki ; A k 1i for all times k such that a) R k;i = 1 and b) A k 1;i = ::: = A 0;i = 0:
To carry out stage 2 for IPTW estimation we must input a vector function b (z; x). A simple choice for b in the model DYR-Par-MSM is b (z; x) = @ @ h par (z; x; ) which under model (11) yields
The IPTW estimator of = ( 1 ; :::; 6 ) in model (11) that uses this choice of b, then solves
2 6 6 6 6 6 6 6 6 6 4
where x is, say, 350.
If, instead, we wish to conduct estimation under the more ‡e x i b l e model DYR-Sem-MSM, then the choice b (z; x) = @ @ h sem (z; x; ) yields under model
The IPTW estimator of = ( 1 ; :::; 4 ) now solves,
where an overbar stands for average over the integers x in [200; 600]:
To construct augmented IPTW estimators of we must choose functions o k ; fd k ( a k )g k=0;:::;K for each k: We postpone the discussion and illustration of convenient choices of d k to Section 5.3.1.
Finally to illustrate the point made earlier that a subject may contribute to several x speci…c estimating functions, consider a subject i whose CD4 count decreased over time, who started HAART at a CD4 count of 250 in some visit and whose previous visit CD4 count was 300. Then this subject's observed data was consistent with having followed regime g x for all x 2 [250; 300): For such subject, ! Thus, subject i enters in the estimating equation for repeatedly over the sum on x; once for every regime g x his data was consistent with. Furthermore, suppose that the subject died in the middle of the third month. Then for this subject R K+1;i = 0 and T K+1;i = 2:5 so his outcome is 2:5: In addition, I fgx;k(Ok;i)g (A k;i ) = k A k;i jO k;i ; A k 1;i = 1 for k = 3; :::; K and consequently, ! 
Asymptotic Distribution of the IPTW and AIPTW Estimators of
In this section we will derive the asymptotic distribution of the IPTW and AIPTW estimators of proposed in the preceding subsection under the assumptions of model DYR-Par-MSM-obs . Our results will require that we make the following strengthening of the PO(X pos ) assumption which states that treatment probabilities of treatments consistent with regimes g x not only are positive but also stay bounded away from zero.
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= 1: Under regularity conditions and the strengthened PO(X pos ) assumption, standard linearization arguments imply that when model DYR--MSM-obs holds,
and for any V; V
which can be consistently estimated with b ;opt are not available for data analysis because they depend on the unknown law of the data, however, we will indicate how to use the knowledge of their functional form to derive locally e¢ cient estimators of in model DYR--MSM-obs for the class of AIPTW estimators that use a …x e d b (a property that is de…ned at the end of Section 5.3.1). In a subsequent section, we will show that these locally e¢ cient estimators are also double-robust, a property that we will de…ne then. In Section 7 we will derive the optimal function b ;opt in the sense that ;opt;k is optimal in the sense that b (b ;opt ; d ;opt ) has the smallest asymptotic variance among the asymptotic variances of all b (b; d) : These optimal functions are also not available for data analysis as they depend on the unknown observed data law, but we will show how to exploit the knowledge of their form to compute estimators of that (i) are locally e¢ cient under model DYR--MSM-obs for the class of all AIPTW estimators and (ii) are double-robust.
E¢ cient Estimation for a Fixed Choice of b
To derive the optimal functions d b ;opt;k ; k = 0; :::; K; we reason as follows. 
d k ; k = 0; :::; K; are arbitrary scalar functionsg .
The second expression for the set indicates that is comprised by sums from k = 0 to K of functions of O k ; A k with mean zero given
3. Suppose that model (16) is correctly speci…ed. Consider the score vector S for evaluated at the true parameter : The j th entry of S is equal to
Since each term @ log k A k jO k ; A k 1 ; =@ j = is a function of O k ; A k with mean zero given O k ; A k 1 ; then every entry of the vector S is an element of the set : and consequently we would obtain the desired inequality
That (25) ;opt with the properties of item 5 indeed exists. To …n d it we reason as follows. The set is a linear and closed subspace of the (Hilbert) space of all mean zero, …n i t e variance, random functions of (O; A) with covariance inner product. By the projection theorem (Luenberger, Ch. 3, Theorem 2, 1969) , for any q 1 random vector Q; there exists a (mean zero, …n i t e variance) q 1 random vector denoted [Qj ] , such that each entry of [Qj ] is in and such that Q
[Qj ] is uncorrelated with all the elements of : The vector [Qj ] is called the projection of Q onto : Because of the special form of ( is a direct sum of K subspaces, the k th one being the set of functions of O k ; A k with mean zero given O k ; A k 1 ) it is a standard calculation to compute [Qj ] for any Q: For completeness, in Section 2.4.1 of the companion paper (Orellana, Rotnitzky and Robins, 2010) we provide this calculation and show that
Applying this result to Q = S ( ; ; b) ; another straightforward calculation, also derived in Section 2.4.3 of the companion paper, gives that
; ;opt;k (o k ; a k ), and where for any ; ;
The preceding argument shows that inclusion of the augmentation term S aug ( ; d), with adequately chosen functions d k ; helps improve the e¢ ciency with which one can estimate : estimating with a non-augmented estimating equation is equivalent to solving equations (17) using d k = 0 for all k; but these null functions are generally not the optimal choices for d k .
Locally E¢ cient Estimation for a Fixed Choice of b
The functions 
where for each x and o k ;
x k+1 (o k ; ) is a smooth function and is an r 1 unknown parameter vector.
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c. Estimate the function d 
and consequently,
Then S ( ) has mean zero and hence P n S ( ) = 0 is an unbiased estimating function for . 
and ! In general, suppose that E is a class of consistent and asymptotically normal estimators of a parameter under all laws P in M. Suppose that for each P 2 M, (P ) is a lower bound for the variance of the limiting distributions (under P ) of the estimators in E: Suppose that there exists an estimator in the class E whose limiting distribution has variance equal to (P ) when P 2 M 0 M. Such estimator is called locally e¢ cient in model M for the class E at the submodel M 0 : According to this de…nition, if DYR--MSM-obs denotes the model that imposes the restrictions of model DYR--MSM-obs and additionally imposes the strengthened PO(X pos ) assumption, the preceding properties According to result, the function T ( ; ; ;b) is equal to the di¤erence of S ( ; ; b) and its projection under the law P ; on the (nonparametric) tangent space for the laws in the L A -part of the likelihood, i.e. the space of scores for all possible parametric submodels for these laws. But this tangent space is precisely the set de…ned in point (2) of Section 5.3 and we have already seen in point (6) of that section (display (27)) how to compute its projection. Furthermore, in Section 5.3.1, we have shown that S ( ; ; b) minus its projection into can be expressed as the function in ( opt . In spite of the preceding general result, with the goal of making this article self-contained, we will now show from direct calculations, that S ; (x; ; ; ), and consequently the function de…ned in (30) evaluated at ; has mean zero if model (29) is correct.
Rearranging terms, we can re-express S ; (x; ; ; ) as
Now,
6 6 6 6 6 6 4
The numerator in the fraction of the last equality is equal to 0 when model (29) is correctly speci…ed and is equal to the true value since
are equal to 0 when model (29) is correctly speci…ed and = : The equality to 0 of the last display follows from the fact that h (x; Z; ) = E [u (O gx ; A gx ) jZ] by the assumption of the dynamic regime MSM model and E (o j ) for j < k (for a discussion of this point see Murphy, van der Laan and Robins, 2001) ; ii) few interaction terms between x and some of the components of o k in the model for Example 1 (continuation): we consider now the construction of a double-robust estimator of in the parametric and semiparametric dynamic regime MSM models h par (z; x; ) and h sem (z; x; ) de…ned like in (11) and (13). To do so we need to specify two models, one for the treatment probabilities, k (a k jo k ; a k 1 ) and another for the functions Case 2) if r k = 1; then our model should distinguish two cases, depending on whether or not the subject's CD4 count has crossed the threshold x or not. Speci…cally, Case 2.1) if CD4 j > x for all j k then in the world in which g x was implemented, a subject with such CD4 recorded history would have not yet started HAART. The expected utility of such subject would depend on the threshold x determining the future value of CD4 count at which the subject will be put on HAART. Furthermore, a patient whose r k = 1 had not yet experienced the event point and, with the de…nition of utility given in the example in Section 5.1, his/her utility will be at least k: So, our model for the expected utility should account for this. In addition, it is reasonable to expect that the utility will be predicted by the CD4 status at time k and that present CD4 could possibly be a modi…er of the e¤ect of starting HAART in the future at di¤erent values of x: One possible model contemplating these considerations could be
which allows for the utility function to be a cubic polynomial in x with coef…c i e nt s that depend on present CD4 k and the clinic visit k: Of course, more ‡e x i b l e models could be envisioned which incorporate dependence not only on current CD4 count but on past CD4 counts and on current and past viral loads. Our ability to …t more ‡e x i b l e models is limited by the sample size of the study. Case 2.2) if CD4 j > x for all j < k and CD4 k x then in the world in which x was implemented, a subject with such CD4 recorded history would start HAART at clinic visit k: A reasonable model would allow for the possibility that the expected utility of such subject is equal to k plus some function that depends on the current CD4 values of the subject and the rate of decline in CD4 at the last interval. As such, we could contemplate postulating that
Note that the case CD4 j x for j < k is not needed because for such k; ! x k 1 ( ) = ! x k ( ) so in the estimating equation (31) the term where
So, …n a l l y, putting the three cases together, our model would be
6.1 Double-Robust Inference for The International Journal of Biostatistics, Vol. 6 [2010 ], Iss. 2, Art. 8 DOI: 10.2202 /1557 -4679.1200 either model is correct and estimate the variance of this limiting distribution with the usual sandwich variance estimator, replacing the unknown model parameters with their estimators. Standard Taylor expansion arguments yield
where Q (x; ; ; ) S ; (x; ; ; ) J ; ( ; ; 
where b Q (x; ; ; ) is de…ned like Q (x; ; ; ) but with the population mean E replaced by the empirical mean P (29) is correctly speci…ed, but not necessarily both. Speci…cally, consider the ellipsoid which has coverage probability equal to the nominal one as n goes to 1 when either model (16) or model (29) hold. Bembom and van der Laan (Appendix C, 2008) also discuss the construction of Wald con…dence regions for x opt (z; ) when X is an open subset except that in their application the treatment probabilities are known by design, and as such their intervals are centered at non-double robust estimators and have length computed based on non-double robust estimates of standard error.
The following lemma gives the set of su¢ cient conditions for the existence of @x opt (z; ) =@ j and an expression for it. is non-singular, then for each z; x opt (z; ) is differentiable with respect to in a neighborhood of and
When X is countable, whether …n i t e or in…nite, the preceding construction is not feasible because the derivative of x opt (z; ) is unde…ned: In this setting, we can consider the set
where x opt (z; ) is de…ned in (20) and C b is the Wald con…dence ellipsoid for of the preceding subsection. This set has coverage probability at least (1 ) as n goes to 1 when either model (16) or model (29) hold. In Section 3 of the companion paper (Orellana, Rotnitzky and Robins, 2010) we show that in the special, but widely applicable, case in which h (z; x; ) is a linear function of the j 's; determining whether or not a given x belongs to B b entails determining if the intersection of # (X ) 1 half-hyperspaces of R p and a ball centered at the origin is non-empty, where # (X ) is the cardinality of the set X . Although e¢ cient algorithms to implement this task may be known in computer science or allied …e l d s , we are not aware that such algorithms exist. In Section 3 of the companion paper (Orellana, Rotnitzky and Robins, 2010) we provide an algorithm to compute a set B b that includes, but is not necessarily included in, B b in the aforementioned special case: Such set B b is therefore a more conservative con…dence set for x opt (z) than B b : An alternative procedure would be to compute a con…dence band for the function that maps x with m (z; g x ) with simultaneous coverage no smaller than (1 ) and, then to construct the set C comprised by all the x's for which the con…dence interval for m (z; g x ) overlaps with the con…dence interval for m z; g xopt(z; b (b; b d b ;opt )) both based on the band. Such set C would cover the true x opt (z) with probability at least (1 ). Bembom and van der Laan (Appendix B, 2008) describe the construction of a simultaneous con…dence band for the map x 7 ! m (z; g x ) when X is …n i t e , by Monte Carlo simulation. 
Speci…cally, in Section 2.5 of the companion paper we show that b ;opt is the solution to the Type I Fredholm integral equations Another point of note is that although the optimal choice b ;opt depends on the choice of P X ; the value taken by b b; d b ;opt does not because if b ;opt solves (35) for a given P X ; then b 0 ;opt = b ;opt dP X =dP 0 X solves the integral equation for P 0 X ; provided P 0 X is absolutely continuous with respect to P X : When X pos = fx j : 1 j Jg is …n i t e and P X is the uniform distribution on X pos ; the solution of equation (35) can be written in closed form. Speci…-cally, b ;opt (x j ; z) 0 is equal to the j th row of the J p matrix
where m (z) is a J p matrix with j th row equal to @h (x j ; z; ) =@ 0 and C (z) is the J J matrix with (j; l) th entry equal to C (x j ; x l ; z) : Of course, b (z) is not available because C (z) is unknown. We may nevertheless consider
where D (z) is the diagonal matrix with diagonal equal to that of C (z) and postulate working variance and correlation models, D jj (z) = D jj (z; ) and R ;jk (z) = R ;jk (z; ) ; 1 j < k J
where for each z; D jj (z; ) and R ;jk (z; ) are unknown smooth functions and and are unknown parameters. For example, we may consider a linear exponential model D jj (z; ) = exp 1;j + 2;j z and a …r s t order autoregressive model R ;jk (z; ) = exp ( jj kj ) for >0:
We may then estimate and as follows. ;opt converges to if either of these models is correct: Because when model (37) holds, the estimator b C (z) is consistent for C (z) ; it follows that when model ;opt is a locally e¢ cient estimator of in model DYR--MSM for the class T of AIPTW
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In practice, the set X pos ; even if …n i t e , may be very large. For instance, in Example 1 of Section 4, X pos has 401 elements. In such case the square matrix b C (z) will be unduly large dimension and its inversion will generally be computationally intractable. For such scenarios, we may consider the following dimension reduction strategy. Let X pos be a subset of X pos with small cardinality J : Let the J p matrix b (z) be de…ned as in the previous parab graph but with X pos instead of X pos . De…ne for each x 2 X pos ; b (x; z) 0 equal to the corresponding row of b (z) : Finally, for any x 0 in X pos X pos set b (x 0 ; z) b equal to one of the following possible choices: i) 0; ii) b (x; z) for x the closest neighbor of x 0 in the Euclidean distance sense, or iii) the linear interpolation between b (x 1 ; z) and b (x 2 ; z) for x 1 and x 2 the two closest neighbors of x 0 , if X pos R : We hypothesize that when the function h (z; x; ) is a smooth function of x; the loss in e¢ ciency due to implementing this strategy will be small if the distribution of the points in X pos is similar to that of the points in X pos ; for example if X pos is comprised of one in every, say, ten (sorted) points in X pos when X pos R: A thorough examination of the properties of this strategy is beyond the scope of this paper.
When X pos is an in…nite but bounded set, we recommend conducting the strategy just described on a set X pos comprised by the points of a grid of X pos of not too large cardinality. Once again, we hypothesize this strategy will not result in substantial e¢ ciency losses when h (z; x; ) is a smooth function of x:
Discussion
The dynamic regime marginal structural mean models developed in this paper have two appealing properties: they are easy to understand and they are easy to …t with standard o¤-the-shelf software that allows for weights. Nevertheless, estimation of the parameters of dynamic regime MSMs has some limitations. First, if the number of time periods is large, the denominator of ! This may result in very large weights for a few compliers with regime x compared to the rest of the compliers in the sample. Even in moderate-sized studies, for estimation of the consequence of this phenomenon in …n i t e samples is bias and variance that is substantially larger than the one prescribed by the asymptotic theory. Second, dynamic regime MSMs do not allow for direct modelling of interactions between treatment and evolving time dependent covariates and so do not permit qualitative e¤ect modi…cation to be considered directly. Finally, it is unclear how to construct extensions of dynamic regime MSMs suitable for assessing the sensitivity to reasonable departures from the assumption of sequential randomization. In contrast, the optimal regime structural nested mean (SNM) model of Robins (2004) does not su¤er from any of these di¢ culties. However, as indicated in the introduction, SNM's cannot be used to estimate the optimal regime in a prespeci…ed parametrized class of regimes (such as the optimal CD4 cell count at which to start HAART) that includes just the set of logistically feasible regimes.
In this paper we have assumed that patients came to the clinic at the end of each of K prespeci…ed intervals. Admittedly, this assumption is unrealistic in most applications. In most observational databases there will be variability across patients in the frequency of, and reasons for, physician visits. This raises many important questions regarding the characteristics of the population in which the optimal treatment regime that we are aiming to estimate will be implemented. Clearly, the optimal treatment strategy depends on the timing of the clinic visits. Methods aiming to estimate the optimal treatment regime will depend on whether i) the subjects comprising the target population in which the regime is to be implemented are biologically similar to those in the population from which the database was obtained, and ii) the health care systems of the target and study populations di¤er for cultural, logistical, and …n a n c i a l reasons in the frequency of, and reasons for physician visits. Orellana and Rotnitzky (2007) and Robins, Orellana and Rotnitzky (2008) 
